Risk-stratified management strategies for HBV reactivation in RA patients receiving biological and targeted therapy: A narrative review

by Yi-Ming Chen, Sheng-Shun Yang, Der-Yuan Chen
Published 2019-02-01

Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?

by Shih-Jer Hsu, Sheng-Shun Yang, Jia-Horng Kao
Published 2020-01-01

Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation

by Chia-Yeh Lai, Sheng-Shun Yang, Shou-Wu Lee, Hsin-Ju Tsai, Teng-Yu Lee
Published 2021-10-01

Direct-Acting Antiviral Therapy for Hepatitis C Virus in Patients with BCLC Stage B/C Hepatocellular Carcinoma

by Shou-Wu Lee, Li-Shu Chen, Sheng-Shun Yang, Yi-Hsiang Huang, Teng-Yu Lee
Published 2022-10-01

The Impact of Sequential Therapies after First-Line Systemic Therapies in Unresectable Hepatocellular Carcinoma

by Shou-Wu Lee, Teng-Yu Lee, Sheng-Shun Yang, Yi-Jie Huang, Yen-Chun Peng
Published 2024-04-01

Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B.

by Yi-Jie Huang, Sheng-Shun Yang, Hong-Zen Yeh, Chi-Sen Chang, Yen-Chun Peng
Published 2019-01-01

Factors Associated with Quality of Life in Chronic Hepatitis C Patients Who Received Interferon Plus Ribavirin Therapy

by Shu-Chuan Chang, Wang-Sheng Ko, Shun-Sheng Wu, Cheng-Yuan Peng, Sheng-Shun Yang
Published 2008-06-01

On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B.

by Yi-Jie Huang, Chi-Sen Chang, Yen-Chun Peng, Hong-Zen Yeh, Sheng-Shun Yang
Published 2017-01-01

Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population

by Shou-Wu Lee, Sheng-Shun Yang, Han-Chung Lien, Yen-Chun Peng, Chung-Wang Ko, Teng-Yu Lee
Published 2022-03-01

The Combining of Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors as First-Line Treatment for Advanced Stage Hepatocellular Carcinoma

by Shou-Wu Lee, Sheng-Shun Yang, Han-Chung Lien, Yen-Chun Peng, Chun-Fang Tung, Teng-Yu Lee
Published 2022-08-01

Critically-Ill Patients with Biliary Obstruction and Cholangitis: Bedside Fluoroscopic-Free Endoscopic Drainage versus Percutaneous Drainage

by Yi-Jun Liao, Wan-Tzu Lin, Hsin-Ju Tsai, Chia-Chang Chen, Chun-Fang Tung, Sheng-Shun Yang, Yen-Chun Peng
Published 2022-03-01

Hepatitis B virus-related mortality in rheumatoid arthritis patients undergoing long-term low-dose glucocorticoid treatment: A population-based study

by Sheng-Shun Yang, Chin-Tun Hung, Shu-Fen Li, Horng-Mo Lee, Yueh-Chin Chung, Hsin-Hua Chen, Shu-Chuan Chang
Published 2018-07-01

Risk of nonpsychotic mental disorders development in antiviral-treated mentally healthy chronic hepatitis C patients: A population-based study

by Shu-Chuan Chang, Chin-Tun Hung, Shu-Fen Li, Horng-Mo Lee, Yueh-Chin Chung, Lee-Wen Pai, Sheng-Shun Yang
Published 2015-09-01

Direct-Acting Antiviral Drugs Reduce Fibromyalgia Symptoms in Patients with Chronic Hepatitis C

by Kuo-Tung Tang, Ching-Chun Lin, Yi-Hsing Chen, Tsai-Ling Liao, Der-Yuan Chen, Sheng-Shun Yang, Chia-Chang Chen
Published 2022-09-01

Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor

by Tsai-Ling Liao, Yi-Ming Chen, Shie-Liang Hsieh, Kuo-Tung Tang, Der-Yuan Chen, Ying-Ying Yang, Hung-Jen Liu, Sheng-Shun Yang
Published 2021-12-01

Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy

by Ying-Cheng Lin, Yen-Ju Chen, Shou-Wu Lee, Teng-Yu Lee, Yi-Hsing Chen, Wen-Nan Huang, Sheng-Shun Yang, Yi-Ming Chen
Published 2021-07-01

Comparable Outcomes of Ultrasound versus Computed Tomography in the Guidance of Radiofrequency Ablation for Hepatocellular Carcinoma.

by Lu-Hung Lee, Jen-I Hwang, Yu-Chi Cheng, Chun-Ying Wu, Shou-Wu Lee, Sheng-Shun Yang, Hong-Zen Yeh, Chi-Sen Chang, Teng-Yu Lee
Published 2017-01-01

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan

by Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, Ya-Yun Lai, Shiou-Hwei Yeh, Hung-Chih Yang, Jia-Horng Kao, Shih-Jer Hsu, Yi-Hsiang Huang, Sheng-Shun Yang, Hsing-Tao Kuo, Pin-Nan Cheng, Ming-Lung Yu, Pei-Jer Chen
Published 2021-11-01

Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C

by Shih-Jer Hsu, Ming-Lung Yu, Chien-Wei Su, Cheng-Yuan Peng, Rong-Nan Chien, Hsien-Hong Lin, Gin-Ho Lo, Wei-Wen Su, Hsing-Tao Kuo, Chao-Wei Hsu, Sien-Sing Yang, Sheng-Shun Yang, Kuan-Chiao Tseng, Albert Qin, Yi-Wen Huang, Wan-Long Chuang
Published 2021-03-01

Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patients

by Jinlin Hou, Edward Gane, Rozalina Balabanska, Wenhong Zhang, Jiming Zhang, Tien Huey Lim, Qing Xie, Chau-Ting Yeh, Sheng-Shun Yang, Xieer Liang, Piyawat Komolmit, Apinya Leerapun, Zenghui Xue, Ethan Chen, Yuchen Zhang, Qiaoqiao Xie, Ting-Tsung Chang, Tsung-Hui Hu, Seng Gee Lim, Wan-Long Chuang, Barbara Leggett, Qingyan Bo, Xue Zhou, Miriam Triyatni, Wen Zhang, Man-Fung Yuen
Published 2024-04-01